IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+22.57%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(+23%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-11.09%
Top 10 Holdings %
Top 10 Hldgs %
43.78%
Holding
155
New
31
Increased
13
Reduced
30
Closed
17
Top Buys
| 1 |
Celldex Therapeutics
CLDX
|
$21.4M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$15.7M |
| 3 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$9.46M |
| 4 |
Gossamer Bio
GOSS
|
$9.15M |
| 5 |
Black Diamond Therapeutics
BDTX
|
$7.49M |
Top Sells
| 1 |
BioXcel Therapeutics
BTAI
|
$22.5M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$21.5M |
| 3 |
argenx
ARGX
|
$14.4M |
| 4 |
Immunovant
IMVT
|
$13.6M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$8.74M |
Sector Composition
| 1 | Healthcare | 96.18% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Celldex Therapeutics
CLDX
$1.47B
| $21.4M | 1.7% | +1,647,439 | New | +$21.4M |
|
2
Ocular Therapeutix
OCUL
$2.12B
| $17.1M | 1.36% | 2,055,977 +497,041 | +32% | +$4.14M |
|
|
BPMC
3
DELISTED
Blueprint Medicines
BPMC
| $15.7M | 1.25% | +201,662 | New | +$15.7M |
|
4
Protara Therapeutics
TARA
$120M
| $15.5M | 1.23% | 527,964 +77,192 | +17% | +$2.26M |
|
|
5
BioXcel Therapeutics
BTAI
$59M
| $14.3M | 1.13% | 268,818 -424,898 | -61% | -$22.5M |
|
|
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
| $13.7M | 1.09% | 507,559 -41,900 | -8% | -$1.13M |
|
7
KalVista Pharmaceuticals
KALV
$678M
| $13.5M | 1.07% | 1,113,395 +166,790 | +18% | +$2.02M |
|
|
SBBP
8
DELISTED
Strongbridge Biopharma plc.
SBBP
| $12.4M | 0.98% | 3,271,238 -121,549 | -4% | -$459K |
|
9
scPharmaceuticals
SCPH
$295M
| $10.8M | 0.86% | 1,468,647 +395,000 | +37% | +$2.91M |
|
10
Ardelyx
ARDX
$1.53B
| $9.64M | 0.77% | 1,392,565 -69,669 | -5% | -$482K |
|
|
STSA
11
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $9.46M | 0.75% | +328,824 | New | +$9.46M |
|
|
12
Gossamer Bio
GOSS
$562M
| $9.15M | 0.73% | +703,999 | New | +$9.15M |
|
|
SAGE
13
DELISTED
Sage Therapeutics
SAGE
| $8.36M | 0.67% | 201,151 +18,100 | +10% | +$753K |
|
|
KDNY
14
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $7.79M | 0.62% | 3,369,976 -268,024 | -7% | -$619K |
|
|
CHMA
15
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $7.69M | 0.61% | 1,429,633 -645,859 | -31% | -$3.47M |
|
16
Kura Oncology
KURA
$686M
| $7.59M | 0.6% | 465,619 -294,184 | -39% | -$4.8M |
|
|
17
Black Diamond Therapeutics
BDTX
$157M
| $7.49M | 0.6% | +177,544 | New | +$7.49M |
|
|
18
Immunovant
IMVT
$2.56B
| $6.87M | 0.55% | 282,163 -560,300 | -67% | -$13.6M |
|
|
BLUE
19
DELISTED
bluebird bio
BLUE
| $6.4M | 0.51% | 104,874 +98,376 | +1,514% | +$6.01M |
|
|
CBAY
20
DELISTED
Cymabay Therapeutics
CBAY
| $5.34M | 0.42% | 1,529,830 -837,020 | -35% | -$2.92M |
|
21
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.33M | 0.42% | 327,771 +109,000 | +50% | +$1.77M |
|
|
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.02M | 0.4% | 981,070 -335,776 | -25% | -$1.72M |
|
|
TCDA
23
DELISTED
Tricida, Inc. Common Stock
TCDA
| $4.86M | 0.39% | 177,002 -2,798 | -2% | -$76.9K |
|
24
Madrigal Pharmaceuticals
MDGL
$9.76B
| $4.82M | 0.38% | 42,554 +2,220 | +6% | +$251K |
|
|
EIDX
25
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $4.77M | 0.38% | +100,000 | New | +$4.77M |
|